For example, blocking Gal-9 and Tim-3 can disrupt the immunosuppressive signals that inhibit T-cell function, while ICIs like anti-PD-1 can further enhance T-cell activity against the tumor. This evidence concerns the gene HAVCR2 and neoplasm.